Is Star recalled?
162 FDA recalls mention Star. The most recent are listed below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Star.
Class II · Moderate risk Terminated Apr 28, 2023
Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class II · Moderate risk Terminated Apr 28, 2023
Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class II · Moderate risk Terminated Apr 28, 2023
Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class II · Moderate risk Terminated Apr 28, 2023
Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class II · Moderate risk Terminated Apr 28, 2023
Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class II · Moderate risk Terminated Apr 28, 2023
Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class II · Moderate risk Terminated Apr 28, 2023
Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class II · Moderate risk Terminated Apr 28, 2023
Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class III · Low risk Terminated Feb 24, 2023
Reason Failed Impurities/Degradation Specifications: An out-of-specification (OOS) result was observed during release testing of one lot for a related…
Class II · Moderate risk Terminated Jun 29, 2022
Reason CGMP Deviations: products were stored outside the drug label specifications.
Class II · Moderate risk Terminated Jun 29, 2022
Reason CGMP Deviations
Class II · Moderate risk Terminated May 6, 2022
Reason Lack of assurance of sterility
Class II · Moderate risk Terminated May 6, 2022
Reason Lack of assurance of sterility
Class II · Moderate risk Terminated Apr 13, 2022
Reason cGMP deviations: Temperature abuse
Class II · Moderate risk Terminated Apr 13, 2022
Reason cGMP deviations: Temperature abuse
Class II · Moderate risk Terminated Apr 13, 2022
Reason cGMP deviations: Temperature abuse
Class II · Moderate risk Terminated Apr 13, 2022
Reason cGMP deviations: Temperature abuse
Class II · Moderate risk Terminated Apr 13, 2022
Reason cGMP deviations: Temperature abuse
Class II · Moderate risk Terminated Apr 13, 2022
Reason cGMP deviations: Temperature abuse
Class II · Moderate risk Terminated Dec 31, 2021
Reason Lack of Assurance of Sterility
Class II · Moderate risk Terminated Oct 25, 2021
Reason Incorrect Product Formulation: An incorrect grade of Crospovidone was used to manufacture the product.
Class II · Moderate risk Terminated Oct 25, 2021
Reason Incorrect Product Formulation: An incorrect grade of Crospovidone was used to manufacture the product.
Class II · Moderate risk Terminated Jul 29, 2021
Reason Lack of Assurance of Sterility
Class II · Moderate risk Terminated Jul 29, 2021
Reason Presence of Forein Tablets/Capsules; Venlafaxine Tablets, USP 37.5 mg found in bottles labeled as Venlafaxine Tablets, USP, 50 mg
Class II · Moderate risk Ongoing Jun 9, 2021
Reason CGMP Deviations: Presence of the N-nitroso-varenicline impurity above FDAs acceptable interim acceptable intake limit